共 11 条
[1]
HMGB1/IL-17A axis: An important mechanism for myocardial ischemia–reperfusion injury.[J].Xiaorong Hu;Weipan Xu;Hong Jiang.International Journal of Cardiology.2014, 2
[2]
Effects of rosuvastatin on ADMA; rhokinase; NADPH oxidase; caveolin-1; hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion : cardiovascular topic.[J].Burma; Oktay;Onat; Elif;Uysal; Ayhan;Ilhan; Necip;Erol; Deniz;Ozcan; Mete;Sahna; Engin.Cardiovascular Journal of Africa.2014, 5
[3]
Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent.[J].Jan Mersmann;Franziska Iskandar;Kathrina Latsch;Katharina Habeck;Vera Sprunck;René Zimmermann;Ralf R. Schumann;Kai Zacharowski;Alexander Koch;Stefanie B. Flohé.Mediators of Inflammation.2013,
[5]
HMGB1: A potential therapeutic target for myocardial ischemia and reperfusion injury.[J].Xiaorong Hu;Wenwen Fu;Hong Jiang.International Journal of Cardiology.2011, 3
[7]
Rosuvastatin Prevents Conduit Artery Endothelial Dysfunction Induced by Ischemia and Reperfusion by a Cyclooxygenase-2–Dependent Mechanism.[J].Andrew Liuni;Mary Clare Luca;Tommaso Gori;John D. Parker.Journal of the American College of Cardiology.2010, 10

